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WHAT THIS PAPER ADDS
 The purpose of this work is to contribute to discussion about whether it is possible to manage local aortic wall infection by
antibiotics and endovascular treatment only, without excision and debridement of surrounding tissue, and whether or not the
placement of a foreign material into the infectious terrain will further worsen the infection.a r t i c l e i n f o
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Objective: To report on the short- and long-term outcomes of patients with primary infected aortic
aneurysm (IAA) treated by stent graft (SG) in two centers.
Material and method: Over a period of 15 years, 32 patients with IAA underwent endovascular treatment.
None had undergone previous aortic surgery. The causal relationship was gastrointestinal infection in 9
patients (28%), endovascular diagnostic/therapeutic procedures/resuscitation in 6 (19%), wound infection
after previous surgeries in 5 (16%), urinary infection in 4 (13%), urology or gastroenterology procedures in
3 (9%), pancreatitis in 2 (6%), endocarditis in 1 (3%) and phlebitis in 1 (3%) patient. We implanted 11
bifurcated, 10 tubular thoracic, 4 aorto-uni-iliac, 4 tubular abdominal and 1 iliac SG. Two other surgeries
were hybrid procedures.
Results: The etiological agent was identiﬁed in 28 (88%) patients. Twenty-six (81%) patients survived the
30-day postoperative period. Sixteen (50%) survived to 1-year follow-up and 13 (40.6%) survived to 3-
year follow-up. Three patients have survived for less than 1 year and a further 3 for less than 3 years,
so far. Among patients with aneurysms situated in central parts of the thoracic and infrarenal aorta there
was a better death/survival ratio than among patients with a proximal or distal aneurysm location.
Conclusion: The implantation of a SG may be an alternative to open surgery in selected groups of patients
with primary IAA. Aneurysms of the central part of the thoracic or abdominal aorta have a more
favorable prognosis with endovascular treatment.
 2012 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Introduction
Primary false aortic aneurysms are caused either by septic
embolization from another source, primary arteritis which leads to
damage of the wall, infection of a pre-existing aneurysm or a post-
traumatic pseudoaneurysm, or by direct transfer from the).
ciety for Vascular Surgery. Publishesurrounding infected tissue.1e4 The most frequently identiﬁed
bacteria are Salmonella and Staphylococcus but a wide range of
other agents have been identiﬁed.2,5e7
Patients undergoing conservative treatment have little chance
of survival, due to the rapid progression of pseudoaneurysms and
the likelihood of spontaneous rupture and bleeding.8 The classical
surgical procedure consists either of the radical removal of the
infected arterial segment and its surroundings contaminated by the
infection, followed by in situ replacement by a prosthesis impreg-
nated with silver ions or rifampicin, or biological replacement
(arterial allograft or autologous femoral vein), or of sealing thed by Elsevier Ltd. All rights reserved.
Figure 1. Number of treated patients with respect to location of the aneurysm.
Table 1
Associated diseases and other important factors (present during the last 12 months
before the outbreak of infectious aortitis).
Comorbidities Number %
Smoking 16 50
Myocardial infarction in medical history 13 40.6
Diabetes compensated by oral
antidiabetics or diet
8 25
Chronic renal failure 6 19
Chronic heart failure 4 12.5
Diabetes mellitus compensated by insulin 2 6.3
Myeloma 2 6.3
Dialysis 2 6.3
Immunosuppressive treatment 1 3.1
Corticosteroid therapy 1 3.1
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anatomic bypass.9e14 In 1998, Semba et al. published a series of
three patients with infectious aneurysms of the thoracic aorta
treated for the ﬁrst time with an endovascular stent graft (SG).15
The placement of prosthetic material in the infected terrain may
be controversial but the short-term and mid-term results are
promising.16e18 An endovascular procedure is recommended in
emergency cases with a contained arterial wall rupture, in high-risk
patients, and in situations with an unfavorable terrain after
previous abdominal or thoracic surgeries. Some authors advocate
using SG only as a temporary bridge to delayed open surgery.19,20
Postoperative removal of infected debris from the aneurysm sac
or surrounding tissue could further improve the results.21,22 Long-
term follow-up data are lacking. We questionwhether it is possible
to manage aortic wall infection by antibiotics and endovascular
treatment alone, without excision and debridement of surrounding
tissue, and whether the placement of a foreign material into the
infectious terrain may not worsen the infection further.
Material and Methods
Our study describes the results from two vascular surgery
centers in Prague, Czech Republic: Department of Vascular Surgery
in Na Homolce Hospital and Department of Cardiovascular Surgery
in General University Hospital. We registered patients with primary
infected aortic aneurysms treated by endovascular approach and
followed them up prospectively.
Our protocol was to perform endovascular stent-grafting in all
patients with primary infected aortic aneurysms, when no previous
artiﬁcial prosthetic material was present. During the same period,
we performed 12 open procedures for primary infectious aortic
inﬂammation, where the anatomical situation was not convenient
for the endovascular method, and 84 open procedures for pros-
thetic infection in the aorto-iliac position (32 in situ allogenic, 41 in
situ prosthetic replacements and 23 extra-anatomic reconstruc-
tions). We preferred open surgery in all cases of prosthesis infec-
tion, where the infected artiﬁcial material had to be completely
removed. For new replacements, we preferred to use fresh arterial
allograft whenever it was available. None of our endovascular
procedures were intended as a bridge for later open surgery. During
the same period, we implanted over 1424 SGs in thoracic or
infrarenal aortic conditions.Cohort
From 1996 to 2010, 32 patients (25 men, 7 women) with a mean
age of 67 years (42e83, median 69) underwent endovascular
treatment in our institutions, due to primary infected aortic
aneurysms. There were 11 thoracic aorta aneurysms (6 in men and
5 in women; 8 primary infections and 3 infections of pre-existing
aneurysms) and 21 abdominal aneurysms (19 in men and 2 in
women; 14 primary infections and 7 infections of pre-existing
aneurysms). None of the patients had a multiple infectious lesion
at the time of ﬁrst presentation. The patients were registered
chronologically according to the time of hospital admission. The
incidence of infected aortic aneurysms varied over the years
(Fig. 1).
Diagnostic criteria
The highly suspected causative etiology was primary bacterial
gastrointestinal infection (colitis) in 9 (28%) patients, coronary
surgery, or cardiac or peripheral vascular catheter procedures in
anamnesis and cardiopulmonary resuscitation in 6 (19%) patients,
wound infection after previous general or orthopedic surgery
procedures in 5 (16%) patients, urinary infection in 4 (13%) patients,
urology or gastroenterology treatments in 3 (9%) patients and
infectious pancreatitis in 2 (6%) patients. Endocarditis was the
cause in 1 (3%) and infectious phlebitis with sepsis in 1 (3%) patient.
None of the patients had undergone previous aortic surgery, no
Table 2
Clinical manifestation.
Clinical manifestation Number %
C-reactive protein (>5 mg/L) 32 100
Positive blood culture examination
acquired before or during the
endovascular procedure
25 78
Morphology typical of infectious aneurysms 25 78
Excentric saccular and irregular
shape typical for false aneurysm
24 75
Infection of pre-existing abdominal aneurysm 6 18.8
Infection of pre-existing thoracic aneurysm 2 6.3
Fever 24 75
Pain 24 75
Leukocytosis (>10.0 G/L) 22 69
Infection inﬁltration into the surrounding tissue 7 22
Intervertebral spaces 4
Psoatic abscess 2
Ischemic colitis 1
Aneurysm rupture, bleeding 3 9.4
Contained rupture (intramural hematoma) 2 6.3
Infection caused aorto-caval ﬁstula 1 3.1
Figure 3. Vertebral destruction caused by spreading infection (arrow). Note large
periaortic inﬁltration. CT scan at admission. From medical history, this patient had
cholecystectomy followed by surgical wound ﬁstula, lasting months, infected by
Salmonella, and he suffered Salmonella sepsis and Salmonella subfrenic abscess
several months before admission. Secondary infection of abdominal aortic aneurysm
known of for years.
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aorto-enteric ﬁstula. Some of the causes occurred in combination.
We found no clear relationship in only 2 (6%) patients. Other
important factors and conditions are listed in Table 1.
All patients were symptomatic at diagnosis. Themain symptoms
were pain and fever, and the laboratory signs were elevated
leukocytes and C-reactive protein. Numerous blood, body ﬂuid and
tissue cultures were performed in all patients. In patients where the
microbiological agent was not speciﬁed before operation, blood
cultures were also taken by blood and debris catheter aspiration
directly from the aneurysm during the endovascular procedure.
These intraoperative cultures were positive in 3 patients out of 6.
The total number of positive hemocultures taken pre- or peri-Figure 2. Contrast-enhanced hyperemic inﬂammatory rim (arrows) of the aneurysm.
CT scan at admission 63 days after an episode of septic fever and diarrhea. Infectious
agent never identiﬁed.operatively was 25. Four positive microbial cultures were acquired
from abscess or perianeurysmal inﬁltrate punctures done during
open hybrid or secondary surgical procedures. Clinical manifesta-
tions are listed in Table 2.Figure 4. Abscess in the left psoatic muscle with gas bubbles (arrow). CT scan at
admission. Staphylococcus aureus identiﬁed from hemocultures and from abscess.
Duration of case history 35 days. In medical history recent repeated PTA and arterial
stent implantation.
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choice diagnostic examination. We distinguished asymmetric
irregular aneurysm shape, periaortic inﬁltration and contrast
saturation of the hyperemic inﬂammatory rim of the aneurysm
(Fig. 2). The spread of the infection in the surrounding tissue lead
in some patients to vertebral destruction (Fig. 3) or formation of
a psoatic abscess (Fig. 4). Air bubbles were rarely present (Fig. 4).
FDG/PET CT (Fig. 5a,b) was performed before surgery in 22
patients. However, in 10 patients the CT ﬁnding of arterial wall
inﬂammation was considered sufﬁcient proof of infectious
etiology. FDG/PET CT was used also during follow-up in selected
patients (Fig. 5c,d).Figure 5. a. Saccular aneurysm of descending aorta with inﬂammatory inﬁltration lining on
anamnesis duration 56 days. CT scan. b. Signiﬁcant metabolic activity typical of infected ane
Arrow points at the thrombosed aneurysms. d. FDG/PET CT after 1 year: metabolic activityAntibiotic regime before and after the procedure
After the diagnosis, 100% of patients received antibiotic treat-
ment lasting from 2 to 31 days (16 days on average) before the
endovascular procedure. In 22 patients, the treatment was targeted
according to the sensitivity identiﬁed from preoperative blood
cultures, and in 6 patients according to microbial cultures from
other body sources. In 4 patients, the antibiotics were purposely
changed depending on the type of infectious agents from the per-
ioperative cultivation. In 4 patients, broad-spectrum antibiotics
were administered for unknown infections. After the procedure,
antibiotic treatment was continued for up to 4e8 weeks dependingCT. Salmonella was captured in hemocultures, infection originated from urinary tract,
urysm on FDG/PET CT. c. CT scan, the same view 1 week after tubular SG implantation.
disappeared, no signs of aneurysm or residual inﬂammation.
Table 4
Identiﬁed infectious agents.
Agents Gram þ/ Number %
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after normalization of leukocytes, CRP, procalcitonine and body
temperature. In patients with Salmonella infection, antibiotic
treatment was changed from intravenous to oral form at the time of
hospital discharge and continued indeﬁnitely. However, in some
Salmonella patients this long-term therapy was discontinued after
several months or years due to adverse reactions, decisions of other
physicians or patient non-compliance, with no signs of recurrent
infection.
Endovascular and surgical procedures
All endovascular procedures were performed in an operating
theatre equipped with a mobile C-Arm OEC 9800 (General Electric
Company, Fairﬁeld, CT, USA) or in a hybrid operating room with
a ﬁxed biplanar device (Axiom Artis, Siemens, Erlangen, Germany)
under total (22 patients) or local (10 patients) anesthesia. In all
cases, the femoral arteries were surgically exposed. The procedure
types are shown in Table 3. In the infrarenal abdominal position, we
used four tubular SGs in cases where the aneurysm was excentric
saccular with a very narrow neck, and when we expected safe
coverage of the aneurysm inﬂow. The reasons for aorto-uni-iliac
type of SG were obliteration or severe stenosis of iliac artery in 3
patients and anatomical reasons in 1 patient. In total, four different
SG products were used: Gore (W.L. Gore, Newark, DE, USA), Endoﬁt
(LeMaitre Vascular, Inc., Burlington, MA, USA), Medtronic (Med-
tronic, Minneapolis, MN, USA) and ELLA (ELLA CS, Hradec Kralove,
Czech Republic).
We registered the incidence of infectious agents and the success
rate of the therapeutic procedure in both short-term (up to 30
postoperative days) and long-term follow-ups. We considered
those patients cured whose laboratory markers decreased to
normal values, who did not have a high temperature, signs of sepsis
or extravasation during the monitoring period, and whose
inﬂammatory picture on CT and FDG/PET CT had diminished.
Diagnosis was by CT AG, which we performed after 1, 3 and 6
months and then yearly. FDG/PET CT was performed at least 3
months after SG implantation, depending on the duration of anti-
biotic treatment.
Results
The average time from the onset of symptoms to the date of
hospitalizationwas 34.6 (7e150) days. Themean time from the ﬁrst
symptoms to diagnosis was 28 (3e136) days. The mean time from
diagnosis to surgery was 11 days. The duration of hospitalization at
our institution was 22.9 (2e190) days. The etiological agents of
infectious disease are summarized in Table 4.
Morbidity and mortality
During the 30-day postoperative period, 6 (18.8%) patients died.
Three (9.4%) died due to progressing sepsis and multiorgan or renalTable 3
Surgical procedure.
Type of procedure/SG Number
Bifurcated 11
Tubular (thoracic) 10
Aorto-uni-iliac 4
Tubular (subrenal) 4
Hybrid procedure (tubular SG and
visceral vessel revascularization)
2
Iliac 1failure. Three (9.4%) patients died from other causes: one of
secondary mycotic infection in post-antibiotic pseudomembranous
colitis, one of acute myocardial infarction (AMI) with a pulmonary
edema, and one of late pulmonary and hepatic failure on the 19th
day after distal leak treatment by an additional extension. Early
mortality is presented in Table 5.
During further follow up with a median of 45 (4e110) months,
another 10 (31.3%) patients died: four (12.5%) due to persistent
infection or infection penetrating into the surrounding tissue (5th,
5th, 11th and 12th month) and six (18.8%) of other causes (colon
tumor with metastases, pneumonia after hip surgery, stroke,
meningioma, other aneurysms, pedal gangrene). Late mortality is
shown in Table 6. The other 16 (50.0%) patients were alive after an
average follow-up period of 42 months (4e86).
Table 7 and Table 8 show the inﬂuence of various aneurysm and
procedure characteristics on short- and long-term results.
Simplicity of SG implantation led to longer survival in comparison
with hybrid procedures or technically compromised results
necessitating secondary endovascular procedures (e.g. SG exten-
sion). Patients with ruptured infected aneurysms had a high peri-
operative mortality of 80%. Perioperative renal failure, multi-organ
failure or AMI had a perioperative mortality of 57%, and operation
during ongoing sepsis resulted in 100% 30-day mortality. Con-
cerning location, patients with aneurysms situated in central parts
of the thoracic and infrarenal aorta had better results than patients
with proximal or distal aneurysms (Table 8). Implantation of
a tubular SG into the subrenal aorta does not meet the requirement
for extensive proximal and distal coverage and safe SG anchoring to
the unaffected aorta. Two out of four tubular abdominal SGs were
either distorted or had a signiﬁcant leak, leading to the death of the
patient. We noticed a difference in survival between the patients
treated by the ﬁrst generation (ELLA CS) and by the second
generation (Gore, Endoﬁt, Medtronic) SGs. The older generation
was associated with higher mortality during 30-day and 1-year
periods (6 patients out of 7), while the new generation showed
better results (30-day and 1-year mortality, 7 patients out of 25).
In two (6.3%) patients, an endoleak was found during long-term
follow-up, one proximal in the thoracic and one distal in the
abdominal position of the bifurcated stent graft. The thoracic SG
was extended, but the patient died following an AMI. Abdominal
endoleak was successfully treated by distal extension (Table 8).
Twenty-six (81.3%) patients survived the 30-day postoperative
period. Sixteen (50%) survived to 1-year follow-up and 13 (40.6%)
survived to 3-year follow-up. Three surviving patients have been
alive for less than 1 year and a further three patients for less than 3
years. A KaplaneMeier curve (Fig. 6) shows the 30-day, 1-year and
3-year simulated survival in our cohort. From the 13th month after
the endovascular procedure, all deaths had causes other than the
primary disease/infection.Salmonella enteritidis  13 40.6
Staphylococcus aureus þ 4 12.5
Staphylococcus MRSA  1 3.1
Pseudomonas aeruginosa  3 9.4
Candida albicans NS 1 3.1
Citrobacter freundii  1 3.1
Listeria monocytogenes þ 1 3.1
Klebsiella pneumoniae  1 3.1
Proteus vulgaris  1 3.1
Serratia marcescens  1 3.1
Streptococcus viridans þ 1 3.1
Not identiﬁed
(1x Staphylococcus epidermidis)
NS 4 12.5
Table 5
Causes of early mortality.
No. Sex Age Clinical
symptoms
Infection localization Infectious
agent
Procedure type
(SG type)
Complications Reintervention Time of death Cause of death
1 Male 81 Pain Subrenal aorta Salmonella Tubular abdominal AMI, SG collapse None 2nd day AMI, pulmonary
edema, retroperitoneal
hemorrhage
2 Female 75 Back pain,
fever
Thoracic aorta Staph. aureus Tubular thoracic Continuing sepsis,
proximal endoleak
None 2nd day Multiorgan failure,
continuing sepsis
3 Female 69 Fever, pain,
ﬂuidothorax
Thoracic aorta
supra-diaphragmatic
Salmonella Tubular, uncovered
part across celiac trunc
Distal endoleak Open conversion
on 2ndp.o. day
4th day Multiorgan failure,
continuing sepsis
destroyed aortic wall
4 Male 72 Pain, ruptured
aneurysm
Above abdominal
aorta bifurcation
Salmonella Bifurcated Candida albicans
sepsis, renal failure
None 15th day Renal failure,
post-antibiotic colitis,
mycotic sepsis
5 Male 62 Pain Subrenal aorta Salmonella Tubular abdominal Distal endoleak,
ascites
Aorto-iliac
extension þ
cross-over bypass
19th day Pulmonary and
hepatic failure
6 Male 66 Back pain,
fever
Above abdominal
aorta bifurcation
Staph. aureus Aorto-uni-iliac
SG þ cross-over bypass
Continuing sepsis,
enterorrhagia,
post-antibiotic colitis
None 22nd day Continuing sepsis,
renal failure
Table 6
Causes of late mortality.
No. Sex Age Clinical
symptoms
Infection localization Infectious agent Procedure type
(SG type)
Complications Reintervention Time of death Cause of death
1 Female 61 Pain, fever Descending thoracic Proteus Hybrid procedure tubular
SG þ aorto-mesenteric
bypass
Mycotic sepsis,
pneumonia, femoral
phlebothrombosis
None 4 months Meningioma, cavernous
sinus thrombosis, hepato-
renal failure, decubital sepsis
2 Female 82 Abdominal
pain, fever
Descending thoracic Pseudomonas
aeruginosa
Tubular Respiratory failure,
gastritis, hematemesis
None 5 months Pedal gangraena sepsis,
refused further surgery
3 Male 67 Back pain Descending thoracic negative (Staph.
epiderm.)
Tubular New dissection in
abdominal aorta and iliacs
None 5 months Continuing sepsis
4 Male 69 Back pain,
paraparesis
Above bifurcation Serratia marcescens Bifurcated Psoatic abscess,
infectious
polyradiculoneuritis
spondylitis L3-L4
Abscess evacuation 5 months Persistent infection,
multiorgan failure
5 Male 60 Abdominal pain Above bifurcation Negative Bifurcated Distal endoleak, SG
iliac leg extension
None 6 months New aneurysm in visceral
abdominal segment, refused
another procedure
6 Male 56 Pain, fever Visceral aorta Klebsiella pneumoniae Hybrid procedure;
branched bypass to
CT, SMA and RA
Spondylodiscitis Neurosurgical
hemilaminectomy
and stabilization
11 months Recurrent sepsis, abscess in
both psoatic muscles
7 Male 62 Asymptomatic Descending thoracic Pseudomonas aeruginosa Tubular Proximal endoleak,
dislocation of SG
Tubular extension
of previous SG after
12 months
12 months Persistent infection, unstable
angina, AMI, cardiogenic shock
8 Male 71 Pain Infrarenal aorta Listeria monocytogenes Aorto-uni-iliac SG þ
cross-over bypass
None None 60 months Stroke
9 Male 67 Pain Infrarenal aorta Salmonella Bifurcated None Cholecystectomy 83 months Pneumonia after hip joint surgery
10 Male 68 Fever Descending thoracic Salmonella Tubular None None 110 months Colon cancer, hepatic metastases
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Discussion
Stent grafts have been successfully used for infectious pseu-
doaneurysms in carotid, femoral, subclavian and brachial
arteries.23e26 Based on our results, the endovascular treatment of
primary infected aneurysms of the thoracic or abdominal aorta is
a possible alternative to open surgery. In patients not suitable for
conventional open surgery, it may be possible to manage local
aortic wall infection by antibiotics and endovascular treatment. The
introduction of a foreignmaterial into the infectious terrainwill not
necessarily further worsen the infection.27 Excision, debridement
of surrounding tissue or drainage of abscesses may be required in
patients where infection has spread to adjacent structures. On the
other hand, usage of a stent graft does not preclude later open
repair, and in a situation of impending rupture it could be used as
a “bridge to surgery”. Both previously ruptured infectious aneu-
rysms and contained ruptures have an unfavorable prognosis - in
our cohort only 20% survived the perioperative period. Patients
with non-ruptured aneurysms localized in the middle part of the
thoracic descending or infrarenal aorta, with sufﬁcient proximal
neck, who underwent a straightforward endovascular procedure
(without the need for secondary endovascular intervention), which
covered as long an adjacent arterial segment as possible, without
limiting organ failure and with successfully pre-operatively
controlled infection, had the greatest chance of long-term survival.
In our experience, patients treated with the ﬁrst generation of
stent grafts had a higher mortality during the 30-day and 1-yearTable 7
Signiﬁcant aneurysm characteristics and their relation to numbers of dead or surviving p
EL: endoleak; SG: stent graft.
Signiﬁcant aneurysm characteristic n Periop.
<30 da
Infectious agent Salmonella 13 4
Staphylococcus 5 2
Pseudomonas 3
Candida, Citrobacter, Listeria 3
Klebsiella, Proteus, Serratia 3
Streptococcus 1
Not identiﬁed 4
Technical feasibility Easy SG 24 2
Hybrid procedure 2
Problematic result of
implantation (EL type I,
SG distortion)
6 4
Secondary endovascular
procedure done
2 1
Secondary open procedure
for abscess, spondylodiscitis
6 1
Other medical conditions Perioperative AMI, RF, MOF 7 4
Operation during ongoing sepsis 3 3
Aneurysm characteristic Non ruptured 27 2
Ruptured 5 4
Extension of infection Limited to aortic wall
and <10 mm
7 1
Inﬂammatory inﬁltration
around aneurysm >10 mm
and <20 mm
6
Inﬂammatory inﬁltration
around aneurysm >20 mm
13 5
Abscess, spondylodiscitis 6
Aneurysm location Thoracic proximal 1
Thoracic central 5 1
Thoracic distal 5 1
Infrarenal proximal 1
Infrarenal central 8
Infrarenal distal 12 4periods, partly because of a higher rate of endoleaks compared to
the second generation devices. According to our observations,
during the initial 3 years of the study, only 50% of patients survived
for over 1 year after the operation.
Targeted antibiotic treatment led to a signiﬁcant decrease in the
high mortality rate normally associated with this diagnosis.
Therefore, maximum effort should be made to identify the infec-
tious agent. From a tactical point of view, it is very important to
ascertain the causative agent before starting antibiotic therapy.
Following microbiological diagnosis, the preoperative period
should be used as effectively as possible for intravenous adminis-
tration of antibiotics, and the stent graft should not be implanted
before the blood cultures are negative.16,17,27 The minimum time to
allow for the beneﬁcial effect of antibiotics is 3e7 days.19,27 During
the setting up/preparation of the stent graft for implantation, it can
be soakedwith an antibiotic solution.28 It is appropriate to continue
antibiotic treatment for 4e8 weeks after surgery; in the case of
Salmonella, a treatment period of at least 6 months is advised and,
according to some sources, life-long antibiotic therapy is recom-
mended in individual cases.16,29 Infection spreading into the
intervertebral spaces, with the subsequent destruction of discs or
retroperitoneal abscess formation, leads to severe complications.
Additional surgical procedures such as excision of infected tissue,
decompression of abscess by incision or percutaneous drainage of
these secondary deposits will improve results, and may help to
eradicate the infection.29,30 Spine stabilization may be accom-
plished in patients with vertebral destruction. A hybrid technique
to treat infected vascular reconstruction, combining stent graft,
surgical revision and vacuum-assistedwound closure, was reported
on recently.31atients. AMI: acute myocardial infarction; RF: renal failure; MOF: multiorgan failure;
death
ys
30 dayse1 year 1e3 years Surviving 3 and
more years
Dead Surviving Dead Surviving
0 2 7
0 2 1
2 0 1
3
3 0
0 1
2 1 1
3 4 0 2 13
2 0
2 0
1 0
2 1 0 1 1
2 0 1
7 3 0 2 13
1
0 1 5
2 1 3
1 1 0 1 5
4 1 0 1
1 0
0 1 0 1 2
3 1
1 0
0 1 0 1 6
2 1 5
Table 8
Signiﬁcant procedure characteristics, technical success and their relation to numbers of dead/surviving patients. Abbreviations: EL: endoleak; AMI: acute myocardial
infarction; XO: cross-over bypass.
Aneurysm localization Procedure/SG type Perioperative course/inﬂuence
on aneurysm/cause of death
Periop. death
<30 days
30 dayse1 year 1e3 years Surviving 3 years
and more
Dead Surviving Dead Surviving
Thoracic proximal Tubular Proximal EL, tubular extension
after 12 months, persistent
infection, unstable angina, AMI
1
Thoracic central Tubular Disappeared in 3 months 1
Tubular Disappeared in 2 months 1
Tubular Successful, no EL 1
Tubular Decreased signiﬁcantly in 12 months 1
Tubular Continuing sepsis, multiorgan failure 1
Thoracic distal Tubular Decreased after 6 months 1
Tubular New dissection in abdominal
aorta and iliacs
1
Tubular Distal EL, open conversion on
2nd day, sepsis, multiorgan failure
1
Hybrid:single bypass to
SMA and tubular SG from
thoracic to visceral aorta,
above renals
Chronic myeloma. Meningioma
and cavernous sinus thrombosis,
hepatorenal failure and decubital sepsis
1
Tubular Respiratory failure, pedal gangrene,
sepsis, refused intervention
1
Infrarenal proximal Hybrid: branched bypass to
left RA, CT and SMA,
tubular SG from thoracic
to abdominal aorta
Spondylodiscitis and recurrent
sepsis after 11 months,
hemilaminectomy and spine
stabilization, evacuation of
abscesses in both psoatic muscles
1
Infrarenal central Bifurcated Disappeared in 24 months 1
Aorto-uni-iliac þ XO Disappeared in 22 months 1
Aorto-uni-iliac þ XO Disappeared in 24 months 1
Tubular Spine stabilization, aneurysm
decreased
1
Bifurcated Signiﬁcantly decreased to
in 36 months
1
Tubular Signiﬁcantly decreased
in 48 months
1
Bifurcated Signiﬁcantly decreased and
inﬁltration disappeared
1
Infrarenal distal
and iliac
Tubular Distal EL type I, conversion
to aorto-uni-iliac SG þ XO
bypass, hepatic and
pulmonary failure
1
Tubular SG distortion, continuing
hemorrhage, AMI, pulmonary edema
1
Bifurcated Disappeared in 3 months 1
Bifurcated Decreased in 36 months 1
Bifurcated Severe thrombocytopenia, 1
Aorto-uni-iliac þ XO Sepsis, enterorrhagia, post
antibiotic colitis, renal failure
1
Iliac tubular Disappeared in 3 months 1
Bifurcated Disappeared in 6 months 1
Bifurcated Distal EL and iliac extension
after 4 months. New aneurysm
in visceral segment after
6 months, refused another
procedure
1
Bifurcated Psoatic abscess drainage,
spine stabilization, persistent
infection, multiorgan failure
1
Bifurcated Pulmonary ﬁbrosis on daily
oxygenotherapy, pulmonary
and renal failure after
procedure, mycotic sepsis
1
Bifurcated Psoatic abscess drainage 1
Aorto-uni-iliac þ XO Psoatic abscess drainage 1
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manage and a relative contraindication to surgical replacement in
situ.32 In our cohort, a gram-negative infection was detected in 20
(62.5%) patients. In the early mortality group, the G-infection was
detected in 4 out of 6 patients (66.7%), and in the group with late
mortality, in 5 out of 8 patients (62.5%).Forty-ﬁve percent of our cohort consisted of people with
impaired immunity such as diabetics, patients dependent on
corticosteroids or immunosuppressive treatment, and patients in
the dialysis program. It is important to emphasize the number of
patients who underwent invasive cardiovascular examinations or
procedures with or without stenting and arterial angiography, or
Figure 6. Cumulative survival rate (a KaplaneMeier curve). Survival after 30 days, 1 year and 3 years is 81.3%, 50% and 40.6%, respectively.
P. Sedivy et al. / European Journal of Vascular and Endovascular Surgery 44 (2012) 385e394 393urinary tract mini-invasive procedures, such as extraction of stones
or stent implantation, or who were resuscitated during this period.
This group totaled 9 patients (28.2%), and the infection occurred
within 12 months post intervention. In our opinion, in all of these
procedures the patients should be prophylactically medicated by
broad-spectrum antibiotics before the procedure, particularly if
they belong to the immunodeﬁcient group. Another risk group is
drug addicts33; however none were included in our cohort.
Modern hybrid diagnostic procedures, particularly PET/CT,
combining the possibility of contrast-enhanced structural (CT) and
metabolic (FDG-PET) imaging within one investigation, allowed
a much more accurate differential diagnosis of infectious aneu-
rysms of the aorta.34 The metabolic activity of the process in the
arterial wall is a suitable marker for monitoring the disease activity
or the therapeutic success rate as a part of long-term patient
monitoring.35
Higher metabolic activity is also shown by so-called inﬂam-
matory aneurysms of the abdominal aorta, which, however, have
a different morphological image.
Infected aortic aneurysm is a disease compromising the patient
not only due to difﬁculties caused by the anatomical localization,
but also by severe systemic impairment resulting from sepsis. The
already demanding surgical procedure is made more problematic
by the patient’s overall exhaustion. The selection of either the
surgical or the endovascular procedure, and especially its timing,
calls for a highly experienced team. It is also beneﬁcial to optimize
the nutritional parameters and support the functions of the
affected organs before intervention. We never intentionally used
stent graft as a “bridge to surgery”. However, in a situation of
imminent rupture it could be considered as a possibility to gain
time. Care for these patients is interdisciplinary.
The organization of a randomized study to compare the results
of endovascular and open procedures, and provide adequate
responses, may be difﬁcult due to the relative rareness of the
condition. However, the results of treatment in large sets may help
determine the appropriate tactics. Swedish authors propose the
establishment of an international registry that would record allatypical pathologies including mycotic pathologies, with various
treatment procedures, including conservative treatment.33 The
results could help deﬁne treatment guidelines.
Conclusion
The implantation of a stent graft may be a possible alternative to
open surgery in selected group of patients with primary infected
aortic aneurysm. Better results were reached in patients whose
aneurysms were located in the central parts of the thoracic or
abdominal aorta. High periprocedural mortality was recorded in
patients with ongoing sepsis, ruptured infected aneurysms, and
with perioperative renal or multi-organ failure.
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